You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 170 No. 1, January 11, 2010 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Patient-Physician Communication
 •Patient Education/ Health Literacy
 •Public Health
 •Public Health, Other
 •Quality of Care
 •Patient Safety/ Medical Error
 •Drug Therapy
 •Adverse Effects
 •Medication Error
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Improving Prescription Drug Warnings to Promote Patient Comprehension

Michael S. Wolf, PhD, MPH; Terry C. Davis, PhD; Patrick F. Bass, MD, MPH; Laura M. Curtis, MS; Lee A. Lindquist, MD, MPH; Jennifer A. Webb, MA; Mary V. Bocchini, BS; Stacy Cooper Bailey, MPH; Ruth M. Parker, MD

Arch Intern Med. 2010;170(1):50-56.

Background  Prior studies have documented a high prevalence of patients who misunderstand prescription drug warning labels, placing them at risk for medication error. We evaluated whether the use of "enhanced print" drug warnings could improve patient comprehension beyond a current standard.

Methods  An evaluation of enhanced print warning labels was conducted at 2 academic and 2 community health primary care clinics in Chicago, Illinois, and Shreveport, Louisiana. In total, 500 adult patients were consecutively recruited and assigned to receive (1) current standard drug warning labels on prescription containers (standard), (2) drug warnings with text rewritten in plain language (simplified text), or (3) plain language and icons developed with patient feedback (simplified text + icon). The primary outcome was correct interpretation of 9 drug warning labels as determined by a blinded panel review of patients' verbatim responses.

Results  Overall rates of correct interpretation of drug warnings varied among standard, simplified text, and simplified text + icon labels (80.3%, 90.6%, and 92.1%, respectively; P < .001). Warnings with simplified text and simplified text + icons were more likely to be correctly interpreted compared with standard labels (simplified text – adjusted odds ratio [AOR] = 2.64; 95% confidence interval [CI], 2.00-3.49; simplified text + icons – AOR = 3.26; 95% CI, 2.46-4.32). Patients' ability to correctly interpret labels was not significantly different with the inclusion of icons (simplified text + icons – AOR = 1.23; 95% CI, 0.90-1.67; P = .20). Low literacy was also an independent predictor of misinterpretation (AOR, 0.65; 95% CI, 0.44-0.94). Patients with marginal and low literacy were better able to correctly interpret warning labels with simplified text + icons compared with labels with simplified text only (marginal literacy – AOR = 2.59; 95% CI, 1.24-5.44; P = .01; low literacy – AOR = 3.22; 95% CI, 1.39-7.50; P = .006).

Conclusions  Simple, explicit language on warning labels can increase patient understanding; the addition of appropriate icons is particularly useful for adults with lower literacy skills. Evidence-based standards are needed to promote patient-centered prescription labeling practices.


Author Affiliations: Health Literacy and Learning Program, Division of General Internal Medicine, Feinberg School of Medicine, Chicago (Drs Wolf and Lindquist and Mss Curtis, Webb, and Bailey), and Department of Learning Sciences, School of Education and Social Policy (Dr Wolf), Northwestern University, Evanston, Illinois; Department of Medicine–Pediatrics, Louisiana State University Health Sciences Center at Shreveport (Drs Davis and Bass and Ms Bocchini); and Department of General Medicine, Emory University School of Medicine, Atlanta, Georgia (Dr Parker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Randomized Controlled Trial Evaluating Pictogram Augmentation of HIV Medication Information
Wilby et al.
The Annals of Pharmacotherapy 2011;45:1378-1383.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2010 American Medical Association. All Rights Reserved.